More cancers diagnosed at early stage following increase in health insurance coverage

May 18, 2017

An analysis of nearly 273,000 patients showed that between 2013 and 2014 there was a 1 percent increase in the percentage of breast, lung, and colorectal cancers diagnosed at the earliest, most treatable stage. Considering the thousands of people diagnosed with these cancers annually, a 1 percent increase in early-stage diagnosis could add up to a significant number of new cases and potentially lead to better outcomes.

Following full implementation of the Affordable Care Act (ACA), this study is the first to explore changes in the proportion of cancers – those that can be detected through screening – diagnosed at stage I. The ACA has had a measurable impact on increasing the number of people with health insurance in the United States. The findings will be presented at the upcoming 2017 ASCO Annual Meeting in Chicago.

"We know from previous research that lack of insurance typically results in diagnosis of cancer at a later, and usually less treatable, stage," said lead study author Xuesong Han, PhD, Strategic Director, Health Policy and Healthcare Delivery Research, American Cancer Society. "Although we only analyzed data from a limited timeframe, the fact that there appears to be a positive trend in diagnosis at an earlier stage in multiple cancers is an encouraging sign."

About the Study

The five types of cancers analyzed in this study have screening methods that allow for detection at an early stage, though in some instances, debate remains over efficacy and appropriate use: mammography for breast cancer, colonoscopy for colorectal cancer, Pap smear and/or HPV test for , spiral computed tomography or CT for lung cancer, and PSA test for prostate cancer.

In this study, researchers from the American Cancer Society used the National Cancer Database, a registry of cancer cases reported by hospitals across the United States, which captures about 70 percent of newly diagnosed cancer cases each year. They focused on patients under 65 years of age who were eligible for cancer screening and diagnosed in 2013 or 2014. As the ACA was implemented in late 2013, the researchers used the first nine months of 2013 as a baseline and compared trends in cancer stage at diagnosis in this period to those in the last nine months of 2014.

Key Findings

Researchers found a 1 percent increase in stage I diagnoses for four of the five cancers detectable by screening: breast (from 47.8 percent to 48.9 percent) and cervical cancer (47.3 percent vs. 48.8 percent, although this difference was not statistically significant) in women, and lung (from 16.6 percent to 17.7 percent) and colorectal cancer (22.8 percent vs. 23.7 percent) in men and women. The exception was prostate cancer for which the percentage of stage I diagnoses fell by 1 percent (from 18.5 percent vs. 17.2 percent).

More research is needed to see if this shift in at diagnosis is a short-term effect or continues over time.

Next Steps

The researchers plan to follow trends over the coming years. They also plan to look beyond these five cancers and examine patterns in population databases that are more generalizable.

Explore further: Affordable Care Act made some cancer screenings more accessible, study says

Related Stories

Affordable Care Act made some cancer screenings more accessible, study says

January 18, 2017
The Affordable Care Act helped make recommended cancer screening more affordable and accessible for millions of Americans, according to new University of Virginia research.

Screening gets top marks for picking up bowel cancer early

January 21, 2016
BOWEL cancer is more likely to be diagnosed at the earliest stage if it is picked up by screening, according to new figures released by Cancer Research UK and Public Health England's National Cancer Intelligence Network today ...

Annual report to the nation: Cancer death rates continue to decline

March 31, 2017
Overall cancer death rates continue to decrease in men, women, and children for all major racial and ethnic groups, according to the latest Annual Report to the Nation on the Status of Cancer, 1975-2014. The report finds ...

Black women more likely to be diagnosed with late stage breast cancer than white women

November 16, 2016
Black African women are nearly twice as likely to be diagnosed with late stage breast cancer as white women in England according to new analysis from Cancer Research UK and Public Health England released today (Wednesday).

Place matters in late diagnosis of colorectal cancer, study finds

January 9, 2017
In addition to a person's race or ethnicity, where they live can matter in terms of whether they are diagnosed at a late stage for colorectal cancer, according to a recent study led by a researcher at the School of Public ...

Second, unrelated malignancies strike 1 in 12 cancer patients

July 11, 2016
(HealthDay)—A new study indicates that 8 percent of patients—or one in 12—already diagnosed with one form of cancer will develop a second unrelated malignancy. The findings were published online July 5 in Cancer.

Recommended for you

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop blood test that spots tumor-derived DNA in people with early-stage cancers

August 16, 2017
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

Popular immunotherapy target turns out to have a surprising buddy

August 16, 2017
The majority of current cancer immunotherapies focus on PD-L1. This well studied protein turns out to be controlled by a partner, CMTM6, a previously unexplored molecule that is now suddenly also a potential therapeutic target. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.